Velotti F - Search Results

1

Epitelial-to-mesenchimal transition and invasion are upmodulated by tumor-expressed granzyme B and inhibited by docosahexaenoic acid in human colorectal cancer cells.

D'Eliseo D, Di Rocco G, Loria R, Soddu S, Santoni A, Velotti F. D'Eliseo D, et al. Among authors: velotti f. J Exp Clin Cancer Res. 2016 Feb 2;35:24. doi: 10.1186/s13046-016-0302-6. J Exp Clin Cancer Res. 2016. PMID: 26830472 Free PMC article.

2

Soluble and cell-associated IL-2 receptor (IL-2R) after local immunotherapy with recombinant interleukin-2 (rIL-2).

Velotti F, Giuffrida A, Cippitelli M, Stoppacciaro A, Tubaro A, Ruco L, Santoni A. Velotti F, et al. Pharmacol Res. 1992 Sep;26 Suppl 2:52-3. doi: 10.1016/1043-6618(92)90595-3. Pharmacol Res. 1992. PMID: 1409326 No abstract available.

3

Differential expression of granzyme A and granzyme B proteases and their secretion by fresh rat natural killer cells (NK) and lymphokine-activated killer cells with NK phenotype (LAK-NK).

Velotti F, Palmieri G, D'Ambrosio D, Piccoli M, Frati L, Santoni A. Velotti F, et al. Eur J Immunol. 1992 Apr;22(4):1049-53. doi: 10.1002/eji.1830220426. Eur J Immunol. 1992. PMID: 1551404

4

Interleukin-2 lengthens extrajunctional acetylcholine receptor channel open time in mammalian muscle cells.

Lorenzon P, Ruzzier F, Caratsch CG, Giovannelli A, Velotti F, Santoni A, Eusebi F. Lorenzon P, et al. Among authors: velotti f. Pflugers Arch. 1991 Oct;419(3-4):380-5. doi: 10.1007/BF00371120. Pflugers Arch. 1991. PMID: 1720892

5

Continuous intra-arterial administration of recombinant interleukin-2 in low-stage bladder cancer. A phase IB study.

Tubaro A, Velotti F, Stoppacciaro A, Santoni A, Vicentini C, Bossola PC, Galassi P, Pettinato A, Morrone S, Napolitano T, et al. Tubaro A, et al. Among authors: velotti f. Cancer. 1991 Jul 1;68(1):56-61. doi: 10.1002/1097-0142(19910701)68:1<56::aid-cncr2820680111>3.0.co;2-z. Cancer. 1991. PMID: 2049753 Clinical Trial.

6

Interleukin-2 suppresses established long-term potentiation and inhibits its induction in the rat hippocampus.

Tancredi V, Zona C, Velotti F, Eusebi F, Santoni A. Tancredi V, et al. Among authors: velotti f. Brain Res. 1990 Aug 13;525(1):149-51. doi: 10.1016/0006-8993(90)91331-a. Brain Res. 1990. PMID: 2173960

7

Overnight incubation of mouse spleen cells in recombinant IL-2 generates cytotoxic cells with NK characteristics from precursors enriched with or devoid of LGL.

Punturieri A, Velotti F, Piccoli M, Herberman RB, Frati L, Santoni A. Punturieri A, et al. Among authors: velotti f. Clin Exp Immunol. 1989 Jan;75(1):155-60. Clin Exp Immunol. 1989. PMID: 2495199 Free PMC article.

8

Granzyme A expression by normal rat natural killer (NK) cells in vivo and by interleukin 2-activated NK cells in vitro.

Velotti F, Palmieri G, Morrone S, Piccoli M, Frati L, Santoni A. Velotti F, et al. Eur J Immunol. 1989 Mar;19(3):575-8. doi: 10.1002/eji.1830190328. Eur J Immunol. 1989. PMID: 2785050

9

Locoregional IL-2 immunotherapy of bladder cancer.

Santoni A, Velotti F, Giuffrida A, Santoni G, Piccoli M. Santoni A, et al. Among authors: velotti f. Immunopharmacol Immunotoxicol. 1997 Feb;19(1):1-13. doi: 10.3109/08923979709038530. Immunopharmacol Immunotoxicol. 1997. PMID: 9049656 Review. No abstract available.

10

Interleukin-2 gene transfer into human transitional cell carcinoma of the urinary bladder.

Milella M, Jacobelli J, Cavallo F, Guarini A, Velotti F, Frati L, Foà R, Forni G, Santoni A. Milella M, et al. Among authors: velotti f. Br J Cancer. 1999 Feb;79(5-6):770-9. doi: 10.1038/sj.bjc.6690124. Br J Cancer. 1999. PMID: 10070868 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters